Nextgen Cancer Solutions Private Limited
About Nextgen Cancer Solutions Private Limited
Data last updated:
Nextgen Cancer Solutions Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 05 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC113900.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkata Subash Lingareddy and Anuradha Acharya.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Royal Demeure Building Plot No.12/2 Sector – 1 HUDA Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nextgen Cancer Solutions Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address3rd Floor Royal Demeure Building Plot No.12/2 Sector – 1 HUDA Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Nextgen Cancer Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nextgen Cancer Solutions Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nextgen Cancer Solutions Private Limited, buy the company report.
Board of directors of Nextgen Cancer Solutions Private Limited
Nextgen Cancer Solutions has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Subash Lingareddy Also directs: Photon Capital Advisors Limited, Coramandel Mining & Exports Private Limited, Mapmygenome India Limited and 4 more | Director | 05 Jan 2017 | 9 Years 9 Months | Current |
| Anuradha Acharya Also directs: Mapmygenome India Limited, Passport2immunity Private Limited | Director | 05 Jan 2017 | 9 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Nextgen Cancer Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nextgen Cancer Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nextgen Cancer Solutions Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nextgen Cancer Solutions Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anuradha Acharya was appointed as Director on 05 Jan 2017.
Frequently asked questions
Nextgen Cancer Solutions is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 05 January 2017 (9+ years old) and is registered under CIN U74999TG2017PTC113900.
Nextgen Cancer Solutions has 2 current directors:
- Venkata Subash Lingareddy - Director
- Anuradha Acharya - Director
The latest financial statements of Nextgen Cancer Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Nextgen Cancer Solutions is U74999TG2017PTC113900. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nextgen Cancer Solutions was incorporated on 05 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Anuradha Acharya was appointed as Director on 05 Jan 2017. Venkata Subash Lingareddy was appointed as Director on 05 Jan 2017.
The registered office of Nextgen Cancer Solutions is at 3rd Floor Royal Demeure Building Plot No.122 Sector – 1 HUDA Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081.
Nextgen Cancer Solutions operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Nextgen Cancer Solutions is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Nextgen Cancer Solutions can be reached at its registered office: 3rd Floor Royal Demeure Building Plot No.122 Sector – 1 HUDA Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
